21
Views
5
CrossRef citations to date
0
Altmetric
Reports

Lipotrope deficiency inhibits cell growth and induces programmed cell death in human breast cancer cell line MCF‐7

, &
Pages 13-19 | Received 01 Jun 1998, Accepted 29 Jul 1998, Published online: 04 Aug 2009
 

Abstract

To determine the effects of lipotrope modification on breast cancer cell growth and cell death, the human breast cancer cell line MCF‐7 was assigned to grow in one of three lipotrope treatment media for four days. The treatment media included lipotrope‐control medium (LCM), containing all required lipotropes; lipotrope‐deficient medium (LDM), lacking all lipotropes but supplying homocysteine instead; and lipotrope‐additive medium (LAM), containing twice as much of each lipotrope as LCM. Cell count and [3H]thymidine incorporation into DNA revealed that LDM slowed cell growth and inhibited cell proliferation in the MCF‐7 cell line. Gel electrophoresis showed significant DNA degradation with the appearance of fragments in LDM‐treated cells, whereas the DNA in LCM and LAM cells was largely intact. The LDM group displayed more apopto‐tic bodies as detected by in situ immunohistochemistry. The gene expression level of bc1–2 was lower in cells treated with LDM than in those treated with LCM and LAM, whereas p53 gene expression did not appear different among the three treatment groups. It is concluded that lipotrope deficiency inhibits cell growth and induces programmed cell death in the human breast cancer cell line MCF‐7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.